These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 15080022)
1. Relationship between body mass index and anti-hypertensive efficacy of doxazosin according to a survey of Japanese patients. Toyonaga S; Nakatsu T; Suezawa C; Matsubara H; Sogou T; Kusachi S J Int Med Res; 2004; 32(2):176-84. PubMed ID: 15080022 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism. Inukai T; Inukai Y; Matsutomo R; Okumura K; Takanashi K; Takebayashi K; Tayama K; Aso Y; Takemura Y J Int Med Res; 2004; 32(2):206-13. PubMed ID: 15080025 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
6. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension. Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390 [TBL] [Abstract][Full Text] [Related]
7. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension. Tamasawa N; Matsui J; Ogawa Y; Gotoh T; Hinata T; Murakami H; Zhi GJ; Suda T J Diabetes Complications; 2000; 14(3):135-9. PubMed ID: 10989321 [TBL] [Abstract][Full Text] [Related]
8. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664 [TBL] [Abstract][Full Text] [Related]
9. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol. González Maqueda I Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523 [TBL] [Abstract][Full Text] [Related]
10. Clinical ease of using doxazosin in BPH patients with and without hypertension. Steers WD; Kirby RS Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605 [TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337 [TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow. Andersson PE; Lithell H Am J Hypertens; 1996 Apr; 9(4 Pt 1):323-33. PubMed ID: 8722435 [TBL] [Abstract][Full Text] [Related]
13. Doxazosin in the current treatment of hypertension. Wykretowicz A; Guzik P; Wysocki H Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163 [TBL] [Abstract][Full Text] [Related]
14. Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. Ahaneku JE Kobe J Med Sci; 1996 Feb; 42(1):19-29. PubMed ID: 8984227 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial. Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246 [TBL] [Abstract][Full Text] [Related]
16. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. Kario K; Matsui Y; Shibasaki S; Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K; J Hypertens; 2008 Jun; 26(6):1257-65. PubMed ID: 18475166 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patients. Spoladore R; Roccaforte R; Fragasso G; Gardini C; Palloshi A; Cuko A; Arioli F; Salerno A; Margonato A Acta Cardiol; 2009 Aug; 64(4):485-91. PubMed ID: 19725441 [TBL] [Abstract][Full Text] [Related]
18. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Ceral J; Solar M Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415 [TBL] [Abstract][Full Text] [Related]
19. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension]. Sanz Guajardo D; Espejo Martínez J An Med Interna; 1997 Jan; 14(1):15-9. PubMed ID: 9091027 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients. Zou D; Grote L; Eder DN; Radlinski J; Hedner J Sleep Med; 2010 Mar; 11(3):325-8. PubMed ID: 20171140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]